| Literature DB >> 25642631 |
Adam Shlien1, Brittany B Campbell2, Richard de Borja3, Ludmil B Alexandrov4, Daniele Merico5, David Wedge4, Peter Van Loo6, Patrick S Tarpey4, Paul Coupland7, Sam Behjati4, Aaron Pollett8, Tatiana Lipman9, Abolfazl Heidari9, Shriya Deshmukh9, Na'ama Avitzur9, Bettina Meier10, Moritz Gerstung4, Ye Hong10, Diana M Merino3, Manasa Ramakrishna4, Marc Remke11, Roland Arnold3, Gagan B Panigrahi3, Neha P Thakkar12, Karl P Hodel13, Erin E Henninger13, A Yasemin Göksenin13, Doua Bakry14, George S Charames15, Harriet Druker16, Jordan Lerner-Ellis17, Matthew Mistry2, Rina Dvir18, Ronald Grant14, Ronit Elhasid18, Roula Farah19, Glenn P Taylor20, Paul C Nathan14, Sarah Alexander14, Shay Ben-Shachar21, Simon C Ling22, Steven Gallinger23, Shlomi Constantini24, Peter Dirks25, Annie Huang26, Stephen W Scherer27, Richard G Grundy28, Carol Durno29, Melyssa Aronson30, Anton Gartner10, M Stephen Meyn31, Michael D Taylor25, Zachary F Pursell13, Christopher E Pearson12, David Malkin32, P Andrew Futreal4, Michael R Stratton4, Eric Bouffet26, Cynthia Hawkins33, Peter J Campbell34, Uri Tabori35.
Abstract
DNA replication-associated mutations are repaired by two components: polymerase proofreading and mismatch repair. The mutation consequences of disruption to both repair components in humans are not well studied. We sequenced cancer genomes from children with inherited biallelic mismatch repair deficiency (bMMRD). High-grade bMMRD brain tumors exhibited massive numbers of substitution mutations (>250/Mb), which was greater than all childhood and most cancers (>7,000 analyzed). All ultra-hypermutated bMMRD cancers acquired early somatic driver mutations in DNA polymerase ɛ or δ. The ensuing mutation signatures and numbers are unique and diagnostic of childhood germ-line bMMRD (P < 10(-13)). Sequential tumor biopsy analysis revealed that bMMRD/polymerase-mutant cancers rapidly amass an excess of simultaneous mutations (∼600 mutations/cell division), reaching but not exceeding ∼20,000 exonic mutations in <6 months. This implies a threshold compatible with cancer-cell survival. We suggest a new mechanism of cancer progression in which mutations develop in a rapid burst after ablation of replication repair.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25642631 DOI: 10.1038/ng.3202
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330